JT
CORT icon

Jupiter Topco’s Corcept Therapeutics CORT Stock Holding History

Jupiter Topco’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
+138,743
New +$8.38M ﹤0.01% 765

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jupiter Topco's CORT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 138,743 shares worth $12.1M. The stake represents ﹤0.01% of the portfolio and ranks #765 among its holdings.

398 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Jupiter Topco held 138,743 shares of Corcept Therapeutics worth $12.1M as of Q2 2026.
  • Corcept Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #765 holding.
  • 398 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.